Method for determining contents of six components of mango cough-relieving tablet by HPLC QAMS (quantitative analysis of multi-components by single-marker) method

A mango and content technology, which is applied in the field of HPLC method for the determination of the content of 6 components in Mango Zhike Tablets by one measurement and multiple evaluations, can solve the problems of high detection cost, complex components and high price, and achieves accurate and reliable method, good repeatability and repeatability. good effect

Active Publication Date: 2020-02-11
PHARMA FACTORY OF GUANGXI TRADITIONAL CHINESE MEDICAL UNIV
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The current quality standard is based on the National Drug Standard (2014) GBZ-0154 issued by the State Food and Drug Administration. This standard only has a simple physical and chemical identification method, which obviously cannot effectively control the quality of the preparation.
Although there have been some literature reports on the separate determination of mangiferin, sodium houttuyfonate and chlorpheniramine maleate in Mango Zhike Tablets by HPLC over the past ten years, the compound preparations of Chinese patent medicines have complex components, and single components can be quantified It is difficult to fully control its quality and consistency of curative effect, and the determinatio

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for determining contents of six components of mango cough-relieving tablet by HPLC QAMS (quantitative analysis of multi-components by single-marker) method
  • Method for determining contents of six components of mango cough-relieving tablet by HPLC QAMS (quantitative analysis of multi-components by single-marker) method
  • Method for determining contents of six components of mango cough-relieving tablet by HPLC QAMS (quantitative analysis of multi-components by single-marker) method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0021] 1. Experimental materials

[0022] 1.1 Experimental reagents, drugs and medicinal materials

[0023] The 11 batches of mango cough tablets were all provided by Guangxi University of Traditional Chinese Medicine Pharmaceutical Factory (batch numbers: 20161201, 20161202, 20170304, 20170401, 20170501, 20170901, 20180601, 20180602, 20180701, 20180702, 20181001). Gallic acid (batch number: 110831-201605, with a mass fraction of 90.8%) and protocatechuic acid (batch number: 110809-201205, with a mass fraction of 99.9%) were purchased from China Institute for Food and Drug Control; high mangiferin (batch number ST216701, purity ≥ 98%), hyperoside (batch number ST008801, purity ≥ 98%), isoquercitrin (batch number: ST114401, purity ≥ 98%) were all purchased from Shanghai Standart Standard Technology Co., Ltd.; mangiferin (batch number wkq18050201, HPLC≥98%) was purchased from Sichuan Weikeqi Biotechnology Co., Ltd. Mango leaf control medicinal material (batch number: 121507-20...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for determining the contents of six components in a mango cough-relieving tablet by HPLC and QSMA methods. The HPLC method with a Phenomenex Gemini C18 column (4.6mm*250 mm, 5 mu m) as the chromatographic column, the acetonitrile (B)-0.1% phosphoric acid aqueous solution (A) as the mobile phase, with gradient elution, and at the flow rate of 1.0 mL/min, the detection wavelength of 258nm, and the column temperature of 30 DEG C is adopted. According to the QSMA method, gallic acid is used as an internal reference substance, relative correction factors (RCF) of protocatechuic acid, mangiferin, homomangiferin, hyperoside and isoquercitrin are established, the contents of the same are calculated via the RCFs, amd determining values are compared with determiningresults via an external standard method for analysis. The determining result of the QSMA method has no significant difference (P is greater than 0.05) from that of the external standard method, the RCFs are high in repeatability, the HPLC and QSMA methods can be used to determine contents of the six components in the mango cough-relieving tablet, and the method of the invention is accurate, reliable, highly repeatable and can be used for quality control of the mango cough-relieving tablet.

Description

technical field [0001] The invention relates to the technical field of component detection of compound preparations of Chinese patent medicines, in particular to a method for determining the contents of six components in Mango Cough Tablets by HPLC. Background technique [0002] Mango cough tablet is a Chinese and Western medicine compound preparation made from dried mango leaf extract, sodium houttuyniatin, and chlorpheniramine maleate. It has the effects of clearing the lungs and reducing phlegm, relieving cough and asthma, and is clinically used to treat cough , asthma, phlegm embolism. Mango cough tablets have been widely used for a long time and have shown good clinical efficacy. The current quality standard is based on the National Drug Standard (2014) GBZ-0154 issued by the State Food and Drug Administration. This standard only has a simple physical and chemical identification method, which obviously cannot effectively control the quality of the preparation. Althoug...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N30/02G01N30/06G01N30/86
CPCG01N30/06G01N30/02G01N30/8679G01N2030/045G01N2030/047
Inventor 罗宇东覃洁萍郭海姣谭安蔷李芳婵
Owner PHARMA FACTORY OF GUANGXI TRADITIONAL CHINESE MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products